Skip to content

The Archive · A Source

Efficacy and Safety of Fixed Doses of Intranasal Esketamine as an Add-on Therapy to Oral Antidepressants in Japanese Patients with Treatment-Resistant Depression

BMC Psychiatry October 2021 pmc.ncbi.nlm.nih.gov/articles/PMC8547110

Reports that cite this source

Japan

← Back to the sources archive